- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04973267
Game Plan for PrEP
August 5, 2024 updated by: Brown University
Game Plan for PrEP: A Pilot Trial of a Web-based Intervention to Help High-risk Men on PrEP Adhere to Their Medication, Reduce Alcohol Use, and Encourage Safe Sex
This small pilot randomized controlled trial will test whether a brief, web-based intervention inspired by the principles of motivational interviewing helps high-risk men who take pre-exposure prophylaxis (PrEP) moderate their alcohol use, and improve key outcomes of PrEP care, including adherence, persistence, and STI rates.
Men with a history of "lapses" in PrEP adherence will be randomly assigned to either (1) use the web-based intervention, called Game Plan for PrEP, or (2) watch video clips encouraging healthy lifestyles (e.g., sleep hygiene, balanced diet; attention-matched control).
Participants will complete STI testing and submit dried blood spot (DBS) samples to facilitate analyses of alcohol use and PrEP adherence biomarkers at baseline, 3-months, and 6-months during the study period.
Participants will also complete online surveys at baseline, 1-month, 3-months, and 6-months during the study period.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This small, pilot randomized controlled trial will explore preliminary evidence for the efficacy of Game Plan for PrEP, a brief, web-based intervention inspired by brief motivational interventions.
The study will test whether Game Plan for PrEP is efficacious in reducing heavy drinking and sexually-transmitted infection (STI) incidence, and improving PrEP adherence/persistence, among heavy drinking men who have sex with men who are on PrEP, but who report a recent history of missing 3 or more consecutive doses in the past month.
In this study, we will randomize 50 gay and bisexual men to receive either (1) Game Plan for PrEP (GP4PrEP) or (2) an attention-matched control at the same PrEP care/monitoring visit that they reported meeting eligibility criteria.
We will use self-report measures of alcohol use collected at 1-, 3-, and 6-months and changes in a biomarker of alcohol use collected at baseline, 3-, and 6-months to explore whether Game Plan for PrEP reduces binge drinking compared with control.
We will also use data from a biomarker of PrEP adherence to explore whether Game Plan for PrEP improves PrEP adherence versus control.
Study Type
Interventional
Enrollment (Actual)
73
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02906
- Brown University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Current male gender
- 18+ years old
- Fluent in English
- Heavy alcohol use in the past month (>5 drinks on a single occasion or >14 drinks in a week)
- Currently prescribed and actively taking PrEP
- Report missing > 3 PrEP doses in a row at least once in the past 3 months.
Exclusion Criteria:
- Reporting a history or risk of complicated alcohol withdrawal
- Reporting currently receiving medications or counseling for an alcohol or drug use disorder
- Injection drug use in the past year
- Positive screen for drug-related disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Game Plan for PrEP
Participants will be asked to use Game Plan for PrEP for however long they wish.
Game Plan for PrEP is a web-based intervention that provides users with feedback about how much their risk for HIV is reduced on PrEP, their risk for bacterial STIs, and helps them make a plan to take their medication regularly and reduce their risk for STIs.
Game Plan for PrEP also providers users with feedback about their alcohol use compared to others in their age group and encourages them to make a plan to reduce it.
|
See arm description.
|
|
Sham Comparator: Lifestyle Habits Videos
Participants in this condition will view several videos that encourage them to adopt sleep hygiene and healthy diet behaviors.
The videos were selected to last as long as the average time users engage with Game Plan for PrEP in its initial modules.
|
Web-based videos providing information on sleep hygiene and proper diet.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pre-exposure Prophylaxis (PrEP) Lapse Days
Time Frame: 6 months
|
Number of participants who reported missing 4+ consecutive days of PrEP doses
|
6 months
|
|
Persistence With Pre-exposure Prophylaxis (PrEP)
Time Frame: Past 6 months
|
Whether or not participants explicitly stopped taking PrEP at some point during the 6-month study period
|
Past 6 months
|
|
Number of Alcohol Drinking Days
Time Frame: Month 1, Month 3, and Month 6
|
The total number of days in which participants reported drinking alcohol in the past 30 days
|
Month 1, Month 3, and Month 6
|
|
Average Number of Drinks Consumed Per Drinking Day
Time Frame: Month 1, Month 3, and Month 6
|
The average number of standard alcoholic drinks consumed when participants reported drinking over the past 30 days
|
Month 1, Month 3, and Month 6
|
|
Number of Heavy Drinking Days (5+ Drinks on a Single Occasion)
Time Frame: Month 1, Month 3, and Month 6
|
The total number of days on which participants reported drinking 5+ drinks in a single day over the past 30 days
|
Month 1, Month 3, and Month 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Phosphatidylethanol Level
Time Frame: Month 3 and Month 6
|
The quantity of phosphatidylethanol (PEth) detected in dried blood spot samples collected at 3- and 6-months, ng/mL
|
Month 3 and Month 6
|
|
Tenofovir Diphosphate Adherence
Time Frame: Month 3 and Month 6
|
The predicted probability of tenofovir diphosphate adherence (>= 4 doses/week) detected in dried blood spot samples collected at 3- and 6-months
|
Month 3 and Month 6
|
|
Any Sexually-transmitted Infection (STI) Diagnosis
Time Frame: 6 Months
|
6 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tyler Wray, PhD, Brown University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2021
Primary Completion (Actual)
February 28, 2023
Study Completion (Actual)
February 28, 2023
Study Registration Dates
First Submitted
July 13, 2021
First Submitted That Met QC Criteria
July 13, 2021
First Posted (Actual)
July 22, 2021
Study Record Updates
Last Update Posted (Actual)
August 28, 2024
Last Update Submitted That Met QC Criteria
August 5, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Slow Virus Diseases
- Urogenital Diseases
- Genital Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
Other Study ID Numbers
- 2105002999
- 5R34AA027195 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol; Harmful Use
-
University of New MexicoNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol; Harmful UseUnited States
-
University of Massachusetts, WorcesterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol; Harmful UseUnited States
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedHeavy Drinking | Harmful; Use, AlcoholUnited States
-
Boston University Charles River CampusNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol; Harmful Use | Sex, UnsafeUnited States
-
KU LeuvenUnknownHarmful; Use, Alcohol | Hazardous; Use, Alcohol
-
Women's College HospitalRecruitingAlcohol; Harmful Use | Tobacco Use | Tobacco Use Cessation | Alcohol Use, UnspecifiedCanada
-
The Hong Kong Polytechnic UniversityNot yet recruitingHazardous Drinking | Harmful Alcohol Use
-
Sykehuset i Vestfold HFSykehuset Innlandet HF; University Hospital, Akershus; Trondheim University Hospital and other collaboratorsActive, not recruitingHarmful Alcohol UseNorway
-
University of Central FloridaEnrolling by invitationAlcohol Use, Underage | Harmful; Use, AlcoholUnited States
-
Daniela Romero ReyesUniversidad Nacional de Educación a DistanciaCompletedAlcohol; Harmful UseMexico
Clinical Trials on Game Plan for PrEP
-
Children's National Research InstituteAmerican Diabetes AssociationCompletedType 1 Diabetes MellitusUnited States
-
CogCubed, CorpCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Florida International UniversityCare 4 U Management, Inc.; Care Resource Community Health Centers, Inc.; Monarch...CompletedHIV Prevention | PrEP AdherenceUnited States
-
University of Massachusetts, WorcesterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingPre-Exposure ProphylaxisThailand
-
Fenway Community HealthMassachusetts General Hospital; Brown University; Emory University; University... and other collaboratorsCompletedHIV | Medication Adherence | Pre-exposure ProphylaxisUnited States
-
Milton S. Hershey Medical CenterActive, not recruitingMelanoma | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Liver Cancer | Genito-Urinary CancerUnited States
-
University of ConnecticutActive, not recruitingHIV Seropositivity | Substance Use | STI | Stigma, SocialUnited States
-
Fenway Community HealthHarvard UniversityCompletedPre-Exposure ProphylaxisUnited States
-
Columbia UniversityNational Institute of Mental Health (NIMH)Recruiting